Literature DB >> 23728937

Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone.

Haiyun Xu1, Hong-Ju Yang, Xin-Min Li.   

Abstract

Cuprizone (CPZ) is a copper-chelating agent and has been shown to induce white matter damage in mice and rats. The compromised white matter and oligodendrocytes (OLs) respond to some antipsychotics in vivo. However, little is known about the effects of antipsychotics on cultured OLs in the presence of CPZ. The aim of this study was to examine effects of some antipsychotics on developing OLs in the presence of CPZ. Oligodendrocyte progenitor cells (OPCs) were prepared from rat embryos; OLs at different developing stages were labeled with specific antibodies; levels of CNP and MBP proteins in mature OLs were assessed by Western-blot analysis; malondialdehyde (MDA) levels and activity of catalase were evaluated as well for an assessment of oxidative stress and antioxidative status. In immunofluorescent staining, CPZ was shown to inhibit the differentiation of cultured OPCs into O4-positive cells, reduce the maturation of O4-positive cells into CNP- and MBP-positive cells, and decrease levels of CNP and MBP in mature OLs. These inhibitory effects of CPZ were ameliorated by clozapine and quetiapine (QUE), but not by haloperidol and olanzapine. Further experiments were performed to explore the mechanism of the protective effects of QUE. QUE attenuated the decreases in CNP and MBP in CPZ-treated OLs, and blocked the CPZ-induced increase in MDA and decrease in catalase activity in cultured OLs. These results are relevant to the pathophysiology and treatment of schizophrenia considering the aberrant white matter development and evidence suggesting the derangement of the oxidant and antioxidant defense system in some of the patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23728937     DOI: 10.1007/s00406-013-0414-3

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  49 in total

1.  Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures.

Authors:  Sohei Kimoto; Aya Okuda; Michihiro Toritsuka; Takahira Yamauchi; Manabu Makinodan; Hiroaki Okuda; Kouko Tatsumi; Yu Nakamura; Akio Wanaka; Toshifumi Kishimoto
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-08-02       Impact factor: 5.067

Review 2.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

3.  Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice.

Authors:  P Chandran; J Upadhyay; S Markosyan; A Lisowski; W Buck; C-L Chin; G Fox; F Luo; M Day
Journal:  Neuroscience       Date:  2011-11-06       Impact factor: 3.590

4.  Plasma total antioxidant status and cognitive impairments in schizophrenia.

Authors:  Xiang Yang Zhang; Da Chun Chen; Mei Hong Xiu; Wei Tang; Feixue Zhang; Lianjing Liu; Yuanling Chen; Jiahong Liu; Jeffrey K Yao; Therese A Kosten; Thomas R Kosten
Journal:  Schizophr Res       Date:  2012-05-01       Impact factor: 4.939

5.  Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination.

Authors:  Yanbo Zhang; Handi Zhang; Lingyan Wang; Wengao Jiang; Haiyun Xu; Lan Xiao; Xiaoying Bi; Junhui Wang; Shenghua Zhu; Ruiguo Zhang; Jue He; Qingrong Tan; Dai Zhang; Jiming Kong; Xin-Min Li
Journal:  Schizophr Res       Date:  2012-05-01       Impact factor: 4.939

Review 6.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05

7.  Oxidative stress disrupts oligodendrocyte maturation.

Authors:  Heather Morein French; Mary Reid; Polina Mamontov; Rebecca A Simmons; Judith B Grinspan
Journal:  J Neurosci Res       Date:  2009-11-01       Impact factor: 4.164

8.  Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.

Authors:  L Xiao; H Xu; Y Zhang; Z Wei; J He; W Jiang; X Li; L E Dyck; R M Devon; Y Deng; X M Li
Journal:  Mol Psychiatry       Date:  2007-08-07       Impact factor: 15.992

9.  Demonstration of an anti-oxidative stress mechanism of quetiapine: implications for the treatment of Alzheimer's disease.

Authors:  Haiyun Xu; Haitao Wang; Lixia Zhuang; Bin Yan; Yingxin Yu; Zelan Wei; Yanbo Zhang; Lillian E Dyck; Steven J Richardson; Jue He; Xiaokun Li; Jiming Kong; Xin-Min Li
Journal:  FEBS J       Date:  2008-07       Impact factor: 5.542

10.  White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia.

Authors:  Haiyun Xu; Xin-Min Li
Journal:  Schizophr Res Treatment       Date:  2011-08-11
View more
  7 in total

1.  The new risk variant CACNA1C and brain circuits in schizophrenia.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03       Impact factor: 5.270

Review 2.  Cannabinoids and glial cells: possible mechanism to understand schizophrenia.

Authors:  Valéria de Almeida; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-01       Impact factor: 5.270

3.  Changes in proinflammatory cytokines and white matter in chronically stressed rats.

Authors:  Ping Yang; Zhenyong Gao; Handi Zhang; Zeman Fang; Cairu Wu; Haiyun Xu; Qing-Jun Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-06       Impact factor: 2.570

4.  Clozapine administration enhanced functional recovery after cuprizone demyelination.

Authors:  Nikki Templeton; Bronwyn Kivell; Amy McCaughey-Chapman; Bronwen Connor; Anne Camille La Flamme
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

Review 5.  Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia.

Authors:  Danielle Gouvêa-Junqueira; Ana Caroline Brambilla Falvella; André Saraiva Leão Marcelo Antunes; Gabriela Seabra; Caroline Brandão-Teles; Daniel Martins-de-Souza; Fernanda Crunfli
Journal:  Front Psychiatry       Date:  2020-04-30       Impact factor: 4.157

Review 6.  Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis.

Authors:  Zheng Zha; Sisi Liu; Yijiang Liu; Chen Li; Lei Wang
Journal:  Antioxidants (Basel)       Date:  2022-07-29

7.  Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13.

Authors:  Ana Caroline Brambilla Falvella; Bradley Joseph Smith; Licia C Silva-Costa; Aline G F Valença; Fernanda Crunfli; Antonio W Zuardi; Jaime E Hallak; José A Crippa; Valéria de Almeida; Daniel Martins-de-Souza
Journal:  Front Mol Neurosci       Date:  2021-05-28       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.